• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Anton Zeilinger
    • scilog Magazine
    • Awards
      • FWF Wittgenstein Awards
      • FWF START Awards
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • Elise Richter
        • Elise Richter PEEK
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
        • Accounting for Approved Funds
        • Labor and Social Law
        • Project Management
      • Project Phase Ad Personam
        • Accounting for Approved Funds
        • Labor and Social Law
        • Project Management
      • Expiring Programs
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open Access Policy
          • Open Access Policy for Peer-Reviewed Publications
          • Open Access Policy for Peer-Reviewed Book Publications
          • Open Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • Twitter, external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

The physiological relevance of bile pigments

The physiological relevance of bile pigments

Karl-Heinz Wagner (ORCID: 0000-0002-1683-7265)
  • Grant DOI 10.55776/P21162
  • Funding program Principal Investigator Projects
  • Status ended
  • Start February 1, 2009
  • End January 31, 2013
  • Funding amount € 331,218
  • E-mail

Disciplines

Health Sciences (30%); Medical-Theoretical Sciences, Pharmacy (70%)

Keywords

    Bilirubin, Biliverdin, Antioxidant, Anti-mutagenicity, Anti-carcinogenicity, Vasoprotection

Abstract Final report

Bile pigments are naturally occurring compounds that are produced in the human body. These pig-ments, called bilirubin and biliverdin, are intensely coloured and can been seen in the skin during jaun-dice (bilirubin) and in the green (biliverdin) and yellow (bilirubin) colour of bruises. In the past, bile pig-ments and bilirubin in particular have been thought of as useless or even harmful compounds because jaundice is associated with disease and occasionally can be toxic. However, in the past 20 years, a growing number of research groups have investigated the possible beneficial effects of bile pigments in human body. Very important early findings showed bile pigments were part of a group of compounds called antioxidants, thereby protecting from free radicals that are produced constantly in the human body. Following studies showed that people with mildly elevated bilirubin concentrations in their blood, suffered lower rates of heart disease, which causes sudden death from heart attack. More recent evidence suggests that bile pigments also prevent compounds that cause cancer, from damaging the genetic program of cells called DNA. Co-incidentally, people with elevated bilirubin concentrations are also less likely to suffer from cancer. Before the real importance of bile pigments in the human body can be realised, the mechanism (the `how`) of their protection from heart disease and cancer must be established. When the bile pigments` mechanism of action is known then scientists can investigate new ways of altering the amount of circulating bile pigments, which existing research suggests could prevent the largest killers of people in Western society (cardio- vascular disease and cancer). A series of studies within this project will focus on revealing the protective effects of bile pigments on the development of cancer. Importantly, the studies will investigate how bile pigments protect from cancer, which is currently unknown. The studies progress from pure science investigations (chemistry) to more complex biological experiments in bacteria, animal and human cells, humans and finally in the bodies of animals. These studies will progressively establish the mechanism and potential of bile pigments to protect from cancer, finally testing whether the compounds could be beneficial in humans and animals. Once the effects of bile pigments in animal models of cancer have been established, we will be in a better position to comment on the physiological importance of these poorly understood naturally occurring compounds and apply our knowledge in humans.

Bile pigments are naturally occurring compounds that are produced in the human body. These pigments, called bilirubin and biliverdin, are intensely coloured and can been seen in the skin during jaundice (bilirubin) and in the green (biliverdin) and yellow (bilirubin) colour of bruises. In the past, bile pigments and bilirubin in particular have been thought of useless or even harmful compounds because jaundice is associated with disease and occasionally can be toxic. Today their positive effects on the organism are well known, mainly as antioxidants, but in large epidemiological studies it was observed that people with mildly elevated bilirubin concentrations in their blood, suffered lower rates of heart disease and other chronic diseases. More recent evidence suggests that bile pigments also prevent compounds that cause cancer, from damaging the genetic program of cells called DNA. Co-incidentally, people with elevated bilirubin concentrations are also less likely to suffer from cancer. Since the mechanism (the how) of their protection was not established the project was aimed to fill the gab und explore their mode of action in comprehensive studies. In bacterial studies it was shown that 8 tested bile pigments (which are all abundant in the human body) were able to reduce the effects of foodborne and chemical mutagens. In human cancer cell lines bile pigments were able to induce DNA damage and apoptosis. In a human study subjects with increased blood bilirubin levels (also known as Gilberts Syndrome) showed an improved lipid metabolism (with lower risk factors such as LDL-cholesterol), lower mediators for inflammation and a lower body mass index. Interestingly, the effects were more pronounced in older subjects. This was also approved in a rat model (normo- vs. hyperbilirubinemic rats). Protection of DNA and chromosomal damage was not observed by bilirubin. Taken together the project could show that bile pigments exhibit essential function in the organism and subjects with increased blood bilirubin are protected by chronic diseases due to their improved lipid metabolism and lower body weight. Furthermore the antimutagenic effect of bile pigments was extensively proven; especially the bile pigment which are found in the GUT were highly active.

Research institution(s)
  • Universität Wien - 100%
International project participants
  • Joanne Therese Blanchfield, University of Queensland - Australia
  • Jiri Neuzil, Czech Academy of Sciences - Czechia

Research Output

  • 550 Citations
  • 14 Publications
Publications
  • 2017
    Title Chronically elevated bilirubin protects from cardiac reperfusion injury in the male Gunn rat
    DOI 10.1111/apha.12858
    Type Journal Article
    Author Bakrania B
    Journal Acta Physiologica
    Pages 461-470
  • 2014
    Title Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling
    DOI 10.1016/j.bbrc.2014.04.150
    Type Journal Article
    Author Bisht K
    Journal Biochemical and Biophysical Research Communications
    Pages 94-99
    Link Publication
  • 2014
    Title Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin
    DOI 10.4172/2155-9899.1000218
    Type Journal Article
    Author Bisht K
    Journal Journal of Clinical & Cellular Immunology
    Pages 1000218
    Link Publication
  • 2021
    Title Oxidative Stress and Related Biomarkers in Gilbert’s Syndrome: A Secondary Analysis of Two Case-Control Studies
    DOI 10.3390/antiox10091474
    Type Journal Article
    Author Wagner K
    Journal Antioxidants
    Pages 1474
    Link Publication
  • 2015
    Title Pre- or post-ischemic bilirubin ditaurate treatment reduces oxidative tissue damage and improves cardiac function
    DOI 10.1016/j.ijcard.2015.08.192
    Type Journal Article
    Author Bakrania B
    Journal International Journal of Cardiology
    Pages 27-33
  • 2013
    Title Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome
    DOI 10.1111/eci.12120
    Type Journal Article
    Author Wallner M
    Journal European Journal of Clinical Investigation
    Pages 912-919
  • 2013
    Title Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome
    DOI 10.1042/cs20120661
    Type Journal Article
    Author Wallner M
    Journal Clinical Science
    Pages 257-264
  • 2012
    Title In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles
    DOI 10.3109/10715762.2012.715371
    Type Journal Article
    Author Mölzer C
    Journal Free Radical Research
    Pages 1369-1377
  • 2012
    Title Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert`s syndrome measured with the micronucleus cytome assay
    DOI 10.1093/mutage/ges039
    Type Journal Article
    Author Wallner M
    Journal Mutagenesis
    Pages 731-735
    Link Publication
  • 2012
    Title In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells
    DOI 10.1016/j.yexcr.2012.12.003
    Type Journal Article
    Author Mölzer C
    Journal Experimental Cell Research
    Pages 536-545
    Link Publication
  • 2012
    Title Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome
    DOI 10.1016/j.freeradbiomed.2012.03.002
    Type Journal Article
    Author Boon A
    Journal Free Radical Biology and Medicine
    Pages 2120-2127
    Link Publication
  • 2012
    Title Bilirubin and beyond: A review of lipid status in Gilbert’s syndrome and its relevance to cardiovascular disease protection
    DOI 10.1016/j.plipres.2012.11.001
    Type Journal Article
    Author Bulmer A
    Journal Progress in Lipid Research
    Pages 193-205
    Link Publication
  • 2012
    Title Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay
    DOI 10.1016/j.tiv.2012.08.004
    Type Journal Article
    Author Mölzer C
    Journal Toxicology in Vitro
    Pages 433-437
    Link Publication
  • 2013
    Title Bilirubin and Related Tetrapyrroles Inhibit Food-Borne Mutagenesis: A Mechanism for Antigenotoxic Action against a Model Epoxide
    DOI 10.1021/np4005807
    Type Journal Article
    Author Mo¨Lzer C
    Journal Journal of Natural Products
    Pages 1958-1965
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • Twitter, external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF